Related Experiment Videos
Adherence as a particular issue with protease inhibitors
1Stanford University Medical Center, CA, USA.
The Journal of the Association of Nurses in AIDS Care : JANAC
|January 1, 1997
Summary
Suboptimal dosing of HIV protease inhibitors can cause drug resistance and lower treatment effectiveness. Educating patients on adhering to complex antiretroviral regimens is crucial for maintaining drug efficacy and preventing HIV drug resistance.
Area of Science:
- Infectious Diseases
- Pharmacology
- Virology
Background:
- Suboptimal dosing of HIV protease inhibitors contributes to the development of drug resistance.
- Complex antiretroviral regimens pose challenges for patient adherence.
- Emergence of resistant HIV strains reduces treatment efficacy.
Purpose of the Study:
- To emphasize the critical need for patient and clinician education on antiretroviral therapy adherence.
- To highlight the consequences of suboptimal dosing with HIV protease inhibitors.
Main Methods:
- This study is a review of current understanding and clinical implications regarding HIV protease inhibitor therapy.
- Analysis of factors contributing to suboptimal dosing and subsequent drug resistance.
Main Results:
- Suboptimal therapeutic doses of HIV protease inhibitors accelerate the emergence of drug-resistant HIV strains.
- Missing doses, taking drug holidays, or partial doses significantly reduces the efficacy of protease inhibitors.
Conclusions:
- Comprehensive patient and clinician education is essential for adherence to complex antiretroviral regimens.
- Strict adherence to prescribed dosing is paramount to prevent the rapid emergence of HIV drug resistance and maintain treatment effectiveness.